title: Increased soluble urokinase plasminogen activator receptor (suPAR) serum levels after granulocyte colony-stimulating factor treatment do not predict successful progenitor cell mobilization in vivo.
authors.forename: Thomas
authors.initials: T
authors.lastname: Fietz
authors.forename: Koichi
authors.initials: K
authors.lastname: Hattori
authors.forename: Eckhard
authors.initials: E
authors.lastname: Thiel
authors.forename: Beate
authors.initials: B
authors.lastname: Heissig
mesh_terms: D015415:Biomarkers / Q000097:blood; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods; D006801:Humans; D007279:Injections, Subcutaneous; D007937:Leukapheresis / Q000379:methods; D008297:Male; D011237:Predictive Value of Tests; D011956:Receptors, Cell Surface / Q000097:blood*; D055293:Receptors, Urokinase Plasminogen Activator
chemical_list: D015415:Biomarkers; C524898:PLAUR protein, human; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D016179:Granulocyte Colony-Stimulating Factor